William Blair & Company’s Compugen CGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEN
RCM
RSCM
RIL
AIM
VIA
William Blair & Company's CGEN Position: Q1 2017 in Review
William Blair & Company sold out of Compugen (CGEN) in Q1 2017, closing a stake of 206,356 shares — an estimated $1.05M sold.
William Blair & Company first reported a position in CGEN in Q2 2013 and held it in 15 quarters. The position peaked at $2.08M in Q3 2013. 40 funds tracked by Wall St. Rank hold CGEN as of Q1 2017.
- William Blair & Company reported no remaining Compugen position as of Q1 2017 after selling out during the quarter.
- William Blair & Company sold 206,356 Compugen shares in Q1 2017, an estimated $1.05M.
- William Blair & Company first reported a position in Compugen in Q2 2013 and held it in 15 quarters.
- William Blair & Company's Compugen position peaked at $2.08M in Q3 2013.
- 40 funds tracked by Wall St. Rank held Compugen as of Q1 2017.
Based on William Blair & Company's 13F filing for Q1 2017, filed 10 May 2017.